‘This is the mental health moment’: Innovation and M&A are helping to boost these stocks to new heights

There’s been a lot of chatter about the mental health crisis since the Covid-19 pandemic. Overall,…

Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing

Sen. Bernie Sanders, left, appears at a news conference with Sen. Ed Markey on issuing subpoenas…

Stocks making the biggest moves midday: Meta, Apple, Intel, Amazon, Clorox and more

Check out the companies making headlines in midday trading. Meta Platforms — The Facebook and Instagram…

Fourth-quarter earnings are shaping up to be the best of 2023, but there’s a catch

Traders work on the floor at the New York Stock Exchange on Feb. 1, 2024. Brendan…

Here are Jim Cramer’s rapid-fire takeaways on 6 stocks in the news Friday

Clorox – The consumer products giant saw a huge earnings beat. It’s also rebounding from last…

S&P 500 futures gain after Meta, Amazon results as jobs report looms: Live updates

Traders work on the floor at the New York Stock Exchange on Feb. 1, 2024. Brendan…

Bristol Myers Squibb results top estimates as new drugs post strong sales growth 

Bristol Myers Squibb reported quarterly earnings and revenue that topped expectations on Friday as its portfolio…

Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs

The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium.  NYSE Big…

Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices

Sen. Bernie Sanders, I-Vt., holds his news conference with Sen. Ed Markey, D-Mass., in the Capitol…

4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry

Health care may be a real challenger to tech this year, a business that can actually…

Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch

Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these…

Biden administration’s Medicare drug price negotiations will face major tests in 2024

Activists protest the price of prescription drug costs in front of the U.S. Department of Health…

Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal

Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14…

If you can’t build the next Ozempic, buy it: Where M&A could be heading in the obesity drug space

Investors are contemplating where and when the next big obesity drug deal will occur. At the…

Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs

CFOTO | Future Publishing | Getty Images Pfizer on Tuesday reported a narrower-than-expected adjusted loss for…